Could targeting our immune responses help in the fight against hypertension? | Result In Brief | CORDIS

For Prof. Guzik there is the additional satisfaction of seeing the research through: thanks to EU-support he has been able to provide the first clinical translation of basic findings in the field that he initiated several years before. And his work doesn’t stop there.

“The project is now being developed further to address whether newly identified molecules and cell subpopulations may serve as valuable therapeutic targets in humans. I have received support from the European Research Council to continue this work and the results of ImmunoTension helped to bring this about.”